SPARCLIFE

Serial Number 97261590
Registration 7629214
700

Registration Progress

Application Filed
Feb 10, 2022
Under Examination
Approved for Publication
Feb 14, 2023
Published for Opposition
Feb 14, 2023
Registered
Dec 31, 2024

Trademark Image

SPARCLIFE

Basic Information

Serial Number
97261590
Registration Number
7629214
Filing Date
February 10, 2022
Registration Date
December 31, 2024
Published for Opposition
February 14, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 31, 2024
Registration
Registered
Classes
005

Rights Holder

Sun Pharma Advanced Research Company Limited

16
Address
17/B, Mahal Industrial Estate,
Mahakali Caves Road, Andheri (East)
Mumbai, Maharashtra 400093
IN

Ownership History

Sun Pharma Advanced Research Company Limited

Original Applicant
16
Mumbai, Maharashtra IN

Sun Pharma Advanced Research Company Limited

Owner at Publication
16
Mumbai, Maharashtra IN

Sun Pharma Advanced Research Company Limited

Original Registrant
16
Mumbai, Maharashtra IN

Legal Representation

Attorney
NANCY A DEL PIZZO

USPTO Deadlines

Next Deadline
1985 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-31)
Due Date
December 31, 2030
Grace Period Ends
June 30, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Dec 31, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 31, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 6, 2024 OP.T T OPPOSITION TERMINATED NO. 999999 Loading...
Dec 6, 2024 TMBN T TTAB RELEASE CASE TO TRADEMARKS Loading...
Dec 6, 2024 OP.D T OPPOSITION DISMISSED NO. 999999 Loading...
Jun 14, 2023 OP.I T OPPOSITION INSTITUTED NO. 999999 Loading...
Feb 22, 2023 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Feb 14, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 14, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 25, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 10, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 30, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 30, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 30, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 23, 2022 ALIE A ASSIGNED TO LIE Loading...
Nov 1, 2022 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Oct 19, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Oct 19, 2022 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Oct 19, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Oct 3, 2022 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Oct 3, 2022 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Sep 23, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 23, 2022 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Sep 23, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Sep 23, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 23, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 15, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 15, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 15, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 9, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 15, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 14, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical, phytopharmaceuticals and medicinal preparations for the prevention and/or treatment of allergies, cancer, cardiovascular diseases, stroke or cerebrovascular accidents, neurological and neurodegenerative diseases, headaches, including migraine, central nervous system trauma, sleep disorders, dizziness, pain, depression, anxiety, addictions, blindness, hearing problems, disorientation, altered mood, obesity and overweight, metabolic disorders, as hypercholesterolemia, hypertriglyceridemia, hyperglycemia; herbal medicines for treating allergies; sanitary preparations for medical purposes; dietetic food adapted for medical uses; food for babies; liquid and powdered formula medicated infant milk; infant formula; formula for special medical purposes for infants; medicated complementary foods for infants and young children; medicated dental preparations for humans, namely, oral pain relief, namely, toothache, dry socket, canker sores, cracked teeth, gum pain; materials for wound dressing, namely, adhesive plasters for medical purposes and medicated patches; materials for stopping teeth, namely, dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides; medicated shampoos; medicated soaps; medicated lotions for sunburn; medicated throat sprays and lozenges; medicated body powders; alcohol-based antibacterial preparations, namely, antibacterial spray; medicated cosmetics; all of the foregoing excluding products related to gene and cell therapies and products primarily indicated for treatment or prevention of vitamin or mineral deficiencies through supplementation

Classification

International Classes
005